Novavax Inc. (NVAX)

4.83
0.14 2.99
NASDAQ : Health Technology
Prev Close 4.69
Open 4.87
Day Low/High 4.75 / 4.88
52 Wk Low/High 0.34 / 51.60
Volume 511.64K
Avg Volume 862.90K
Exchange NASDAQ
Shares Outstanding 23.92M
Market Cap 109.09M
EPS -10.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

New Data From Novavax Phase 3 Prepare™ Trial Of ResVax™ Presented At 2019 IDSOG Annual Meeting

New Data From Novavax Phase 3 Prepare™ Trial Of ResVax™ Presented At 2019 IDSOG Annual Meeting

Data demonstrate significant vaccine efficacy against infant pneumonia through the first year of life

Novavax Reports Second Quarter 2019 Financial Results

Novavax Reports Second Quarter 2019 Financial Results

Agreement with the FDA on Phase 3 non-inferiority immunogenicity study design for NanoFlu™ NanoFlu pivotal Phase 3 clinical trial expected to initiate in the third quarter of 2019 with top-line data in the first quarter of 2020 Strategic partnership...

Novavax Reaches Agreement With The FDA On Pivotal Phase 3 Trial Design For NanoFlu

Novavax Reaches Agreement With The FDA On Pivotal Phase 3 Trial Design For NanoFlu

Clinical trial expected to initiate in the fall of 2019

Novavax And Catalent Announce Closing Of Strategic Partnership

Novavax And Catalent Announce Closing Of Strategic Partnership

GAITHERSBURG, Md., July 31, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc.

NVAX: Insiders Vs. Shorts

NVAX: Insiders Vs. Shorts

The most recent short interest data was recently released for the 04/15/2019 settlement date, and Novavax, Inc. is one of the most shorted stocks of the Russell 3000, based on 7.49 "days to cover" versus the median component at 5.30.

Take a Poker Player's Approach to Playing Small Biotech Stocks

Take a Poker Player's Approach to Playing Small Biotech Stocks

As Kenny Rogers sang, you've got to know when to hold 'em and know when to fold 'em… and sometimes when not to play a hand at all.

Interesting NVAX Put And Call Options For March 15th

Interesting NVAX Put And Call Options For March 15th

Investors in Novavax, Inc. saw new options begin trading this week, for the March 15th expiration.

Interesting NVAX Put And Call Options For February 15th

Interesting NVAX Put And Call Options For February 15th

Investors in Novavax, Inc. saw new options begin trading this week, for the February 15th expiration.

First Week Of July 2019 Options Trading For Novavax (NVAX)

First Week Of July 2019 Options Trading For Novavax (NVAX)

Investors in Novavax, Inc. saw new options become available this week, for the July 2019 expiration.

NVAX: Insiders Vs. Shorts

NVAX: Insiders Vs. Shorts

The most recent short interest data was recently released for the 10/15/2018 settlement date, and Novavax, Inc. is one of the most shorted stocks of the Russell 3000, based on 8.21 "days to cover" versus the median component at 4.82.

First Week Of December 21st Options Trading For Novavax (NVAX)

First Week Of December 21st Options Trading For Novavax (NVAX)

Investors in Novavax, Inc. saw new options become available this week, for the December 21st expiration.

First Week Of November 16th Options Trading For Novavax (NVAX)

First Week Of November 16th Options Trading For Novavax (NVAX)

Investors in Novavax, Inc. saw new options become available this week, for the November 16th expiration.

NVAX: Insiders Vs. Shorts

NVAX: Insiders Vs. Shorts

The most recent short interest data was recently released for the 07/13/2018 settlement date, and Novavax, Inc. is one of the most shorted stocks of the Russell 3000, based on 18.69 "days to cover" versus the median component at 6.06.

First Week of NVAX October 19th Options Trading

First Week of NVAX October 19th Options Trading

Investors in Novavax, Inc. saw new options become available this week, for the October 19th expiration.

First Week of March 16th Options Trading For Novavax (NVAX)

First Week of March 16th Options Trading For Novavax (NVAX)

Investors in Novavax, Inc. saw new options become available this week, for the March 16th expiration.

Insiders Were Right: NVAX Makes New 52-Week High

Insiders Were Right: NVAX Makes New 52-Week High

In trading on Wednesday, shares of Novavax, Inc. touched a new 52-week high of $1.98/share.

TheStreet Quant Rating: D- (Sell)